Skip to main content
. 2019 May 17;6(4):667–677. doi: 10.1002/ehf2.12448

Table 3.

Primary and secondary endpoints

HiLo‐HF registry HiLo‐HF pilot RCT
All (n = 36) High SpO2 target (n = 18) Low SpO2 target (n = 18) P‐value
NT‐proBNP
Baseline, pg/mL 14 140.1 (5570.6, 27 806.6) 15 987.9 (6025.6, 29 785.5) 10 262.5 (4355.3, 27 223.0) 0.45a
72 h, pg/mL 7108.9 (4310.5, 17 007.0) 6479.7 (4529.5, 12 304.9) 10 156.8 (4001.8, 17 133.8) 0.72a
ΔNT‐proBNP, pg/mL −3971.4 (−11 194.5, −1049.5) −6963.5 (−13 345.1, −1 253.3) −2093.1 (−5692.1, −353.5) 0.46a
72 h to baseline ratio 0.7 (0.5, 0.8) 0.7 (0.3, 0.8) 0.6 (0.5, 0.9) 0.51b
Secondary endpoints
HiLo‐HF registry (n = 43) All (n = 39) High SpO2 target (n = 18) Low SpO2 target (n = 21) P‐value
VAS
ΔVAS, mm 15 (5, 35) 10 (5, 25) 10 (5, 25) 10 (7, 20) 0.86b
VAS AUC, mm·h 5295 (4537, 5983) 5160 (4380, 5932) 5160 (4050, 6150) 5167 (4552, 5703) 0.73
PGA
ΔPGA, mm 20 (10, 30) 10 (0, 20) 5 (0, 20) 10 (0, 15) 0.91b
PGA AUC, mm·h 4320 (3360, 5280) 4620 (3840, 5760) 4860 (4290, 5775) 4320 (3795, 5670) 0.63
PEF
ΔPEF, L/min 45 (0–80) 47.5 (20, 75) 52.5 (20, 90) 42.5 (25, 67.5) 0.52b
PEF AUC, L/min·h 19 920 (12 795, 24 840) 16 740 (14 610, 22 110) 15 660 (12 540, 19 500) 18 960 (16 080, 24 840) 0.19
Diuretic response
72 h/baseline weight ratio 0.96 (0.94, 0.98) 0.96 (0.94, 0.98) 0.97 (0.94, 0.98) 0.96 (0.93, 0.97) 0.55

Note: AUC, area under the curve; HiLo, high‐dose oxygen/low‐dose oxygen; NT‐proBNP, N‐terminal pro‐brain‐type natriuretic peptide; PEF, peak expiratory flow; PGA, patient global assessment; RCT, randomized controlled trial; VAS, visual analogue scale.

a

P‐value based on comparison of high and low SpO2 groups on logarithmic scale.

b

Test of difference at 72 h adjusting for baseline applying the analysis of covariance model. Unless described otherwise, median (25th percentile, 75th percentile) are reported.